PharmaSGP Holding SE
DUS:PSG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PharmaSGP Holding SE
DUS:PSG
|
DE |
|
Aleatica SAB de CV
BMV:ALEATIC
|
MX |
|
Rio Tinto Ltd
OTC:RTNTF
|
AU |
|
C
|
Computacenter PLC
F:COUD
|
UK |
|
P
|
PharmaSGP Holding SE
F:PSG
|
DE |
|
Saipem SpA
F:SPE1
|
IT |
|
Essity AB (publ)
F:ESW
|
SE |
|
T
|
Trane Technologies PLC
XBER:2IS
|
IE |
|
Premia SA
F:3FDA
|
GR |
|
F
|
Freeport-McMoRan Inc
XMUN:FPMB
|
US |
|
E
|
Eli Lilly and Co
XHAM:LLY
|
US |
|
Bridgestone Corp
OTC:BRDCY
|
JP |
|
A
|
Air China Ltd
XBER:AD2
|
CN |
|
R
|
Royal Mail PLC
XBER:RYE
|
UK |
|
N
|
Nov Inc
XMUN:NO8
|
US |
|
Alps Group Inc
NASDAQ:ALPS
|
MY |
Bankruptcy Probability
PharmaSGP Holding SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PharmaSGP Holding SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
PharmaSGP Holding SE
XETRA:PSG
|
345.3m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
634.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
311.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
240.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
220.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
275.5B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PharmaSGP Holding SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PharmaSGP Holding SE has total debt of 58.1m EUR. This includes both short-term (0 EUR) and long-term (58.1m EUR) debt.
You can find a full breakdown on its Balance Sheet.
